| 臺大學術典藏 |
2022-03-04T06:53:43Z |
Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility
|
Kuo T.-C.; CHING-TING TAN; Chang Y.-W.; Hong C.-C.; Lee W.-J.; Chen M.-W.; Jeng Y.-M.; Chiou J.; Yu P.; Chen P.-S.; Wang M.-Y.; Hsiao M.; Su J.-L.; Kuo M.-L. |
| 臺大學術典藏 |
2022-03-04T06:53:41Z |
erratum: Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility (The Journal of clinical investigation (2013) 123 3 (1082-1095) PII: 91882)
|
Kuo T.-C.; CHING-TING TAN; Chang Y.-W.; Hong C.-C.; Lee W.-J.; Chen M.-W.; Jeng Y.-M.; Chiou J.; Yu P.; Chen P.-S.; Wang M.-Y.; Hsiao M.; Su J.-L.; Kuo M.-L. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference
|
Kuo T.-C.; Huang K.-Y.; Yang S.-C.; Wu S.; Chung W.-C.; YIH-LEONG CHANG; Hong T.-M.; Wang S.-P.; Chen H.-Y.; Hsiao T.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-07T07:49:00Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; SUNG-HSIN KUO; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-01-07T08:39:46Z |
Antecedent Administration of Glutamine Benefits the Homeostasis of CD4+ T Cells and Attenuates Lung Injury in Mice With Gut-Derived Polymicrobial Sepsis
|
Lei C.-S.; Wu J.-M.; Lee P.-C.; Kuo T.-C.; PO-DA CHEN; Hou Y.-C.; Yeh S.-L.; Lin M.-T. |
| 臺大學術典藏 |
2022-01-05T03:36:40Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; KUN-HUEI YEH |
| 國立成功大學 |
2022 |
Gold-Catalyzed Rearrangement of α-Carbonyl Cyclopropanes to Form 3-(Cyclopenta-1,3-dien-1-ylmethyl)oxindoles via a Postulated 1,5-Enolate Shift
|
Sasane, A.V.;Kuo, T.-C.;Cheng, M.-J.;Liu, R.-S. |
| 國立成功大學 |
2022 |
Gold(I)-Catalyzed Highly Diastereo- and Enantioselective Constructions of Bicyclo[3.2.1]oct-6-ene Frameworks via (4 + 3)-Cycloadditions
|
Tanpure, S.D.;Kuo, T.-C.;Cheng, M.-J.;Liu, R.-S. |
| 國立成功大學 |
2022 |
Reactions of thioalkynes with diarylketenes via [3+2]-annulation versus benzannulation using Au and P(C6F5)3 catalysts
|
More, S.A.;Sadaphal, V.A.;Kuo, T.-C.;Cheng, M.-J.;Liu, R.-S. |
| 國立成功大學 |
2022 |
Gaseous CO2Coupling with N-Containing Intermediates for Key C-N Bond Formation during Urea Production from Coelectrolysis over Cu
|
Yang, G.-L.;Hsieh, C.-T.;Ho, Y.-S.;Kuo, T.-C.;Kwon, Y.;Lu, Q.;Cheng, M.-J. |
| 臺大學術典藏 |
2021-09-15T06:19:19Z |
Lipidomics of children and adolescents exposed to multiple industrial pollutants
|
Chen C.-H.S.; Kuo T.-C.; Kuo H.-C.; Tseng Y.J.; Kuo C.-H.; Yuan T.-H.; CHANG-CHUAN CHAN |
| 臺大學術典藏 |
2021-09-15T01:20:48Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; CHIA-LANG HSU; Juan H.-F.; Lee P.-H.; Huang M.-C. |
| 臺大學術典藏 |
2021-08-31T06:29:42Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:35Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-24T06:21:22Z |
Fasting but not changes of plasma metabolome during oral glucose tolerance tests improves the diagnosis of severe coronary arterial stenosis
|
Hung C.-S.; Li H.-Y.; Kuo C.-H.; MAO-SHIN LIN; Kuo T.-C.; Tsai S.-J.; Liu P.-H.; Lin C.-H.; Yang C.-Y.; Chuang L.-M.; Chen M.-F.; Tseng Y.J.; Kao H.-L. |
| 臺大學術典藏 |
2021-08-20T02:45:41Z |
Human Breathomics Database
|
Kuo T.-C.; Tan C.-E.; Wang S.-Y.; Lin O.A.; Su B.-H.; Hsu M.-T.; Lin J.; Cheng Y.-Y.; Chen C.-S.; Yang Y.-C.; KUO-HSING CHEN; Lin S.-W.; Ho C.-C.; Kuo C.-H.; Tseng Y.J. |
| 臺大學術典藏 |
2021-08-18T07:39:08Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang S.-H.; Kuo T.-C.; Wu H.; JHE-CYUAN GUO; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; JHE-CYUAN GUO; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:27Z |
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; Wu C.-H.; Chen X.-J.; Kuo T.-C.; YANG SHIH-HUNG; Shih I.-L.; Lai H.-S.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-12T04:01:27Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
YANG SHIH-HUNG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:25Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
YANG SHIH-HUNG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:25Z |
Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; YANG SHIH-HUNG; Wu C.-H.; Kuo T.-C.; Shih I.-L.; Yen R.-F.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-12T04:01:21Z |
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v
|
Kuo T.-C.; Wu M.-H.; YANG SHIH-HUNG; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. |
| 臺大學術典藏 |
2021-08-10T03:53:04Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-10T03:53:04Z |
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; Wu C.-H.; Chen X.-J.; Kuo T.-C.; SHIH-HUNG YANG; Shih I.-L.; Lai H.-S.; Shih T.T.-F. |
